66 related articles for article (PubMed ID: 663298)
1. [In vitro and vivo studies of the effect of Canesten on yeast-like fungi].
Szarmach H; Małyszko E; Trybuła J; Poniecka H; Stepka L; Wroński A
Przegl Dermatol; 1978; 65(2):205-8. PubMed ID: 663298
[No Abstract] [Full Text] [Related]
2. [Sensitivity of Candida to clotrimazole and myconazole].
Budak A; Pawlik B; Macura A; Laskownicka Z
Med Dosw Mikrobiol; 1978; 30(2):123-7. PubMed ID: 703417
[No Abstract] [Full Text] [Related]
3. Laboratory and clinical studies with clotrimazole.
Holt RJ
Postgrad Med J; 1974 Jul; 50 Suppl 1():24-6. PubMed ID: 4619452
[No Abstract] [Full Text] [Related]
4. [Clotrimazole (Canesten) in the treatment of vulvar mycosis].
Wojcik J; Stozek K; Pawlik B
Ginekol Pol; 1982; 53(5-6):453-8. PubMed ID: 6761239
[No Abstract] [Full Text] [Related]
5. [Ultrastructure of Candida albicans in vitro and in vivo and its changes under exposure to canesten].
Delektorskii VV; Pavlova GV; Iashkova GN; Dmitriev GA
Vestn Dermatol Venerol; 1979 Mar; (3):30-4. PubMed ID: 371234
[No Abstract] [Full Text] [Related]
6. Superficial mycoses and in vitro sensitivity of dermatophytes and Candida species to tolciclate and clotrimazole.
Jacob Z; Wahab S; Ghosh M; Srivastava OP
Indian J Med Res; 1981 Sep; 74():365-71. PubMed ID: 7319573
[No Abstract] [Full Text] [Related]
7. [Phenomenon of increased resistance of yeast-like fungi to nystatin].
Nierebińska E; Gwieździński Z; Urbanowski S; Pracz M
Wiad Lek; 1992 Jun; 45(11-12):427-9. PubMed ID: 1441524
[TBL] [Abstract][Full Text] [Related]
8. [The effect of clotrimazole (Canesten) on the ultrastructure of molds (Aspergillus fumigatus) in the infected animal].
Voigt WH
Mykosen; 1976 Oct; 19(10):345-53. PubMed ID: 794709
[No Abstract] [Full Text] [Related]
9. [Investigation of the activity of the preparation cerbiden against Candida spp].
Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
[TBL] [Abstract][Full Text] [Related]
10. On the mode of action of antimycotics, especially of clotrimazole (Canesten), on the ultrastructural level of human pathogenic fungi.
Voigt WH
Scand J Infect Dis Suppl; 1978; (16):51-8. PubMed ID: 285460
[No Abstract] [Full Text] [Related]
11. [Induction of resistance of yeast-like fungi to synthetic antifungal agents].
Pawlik B; Hołuj-Gubała J; Dźwigaj-Stokłosa W
Med Dosw Mikrobiol; 1983; 35(1):43-8. PubMed ID: 6633032
[No Abstract] [Full Text] [Related]
12. [Experimental study of the antimycotic effect of clotrimazole in vitro and in vivo when administered locally].
Plempel M; Bartmann K
Arzneimittelforschung; 1972 Aug; 22(8):1280-9. PubMed ID: 4678389
[No Abstract] [Full Text] [Related]
13. Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery
Drugs; 1975; 9(6):424-47. PubMed ID: 1097234
[TBL] [Abstract][Full Text] [Related]
14. Antimycotic properties of clotrimazole.
Plempel M; Büchel KH; Bartmann K; Regel E
Postgrad Med J; 1974 Jul; 50 Suppl 1():11-2. PubMed ID: 4467159
[No Abstract] [Full Text] [Related]
15. [In vitro sensitivity of Trichomonas vaginalis to canestan (clotrimazole)].
Szarmach H; Malyszko E; Zaremba A; Trybula J; Poniecka H; Zajac W; Stepka L
Przegl Dermatol; 1976; 63(6):819-22. PubMed ID: 1087423
[No Abstract] [Full Text] [Related]
16. [Treatment of otomycoses with clotrimazole (Canesten)].
Reinecke M
Med Welt; 1976 Jul; 27(27):1349-50. PubMed ID: 785143
[No Abstract] [Full Text] [Related]
17. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Jandourek A; Brown P; Vazquez JA
Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
[No Abstract] [Full Text] [Related]
18. [Characteristics of yeast-like fungi of Candida species isolated from patients in the process of treatment with levorin preparations].
Egorenkova AN; Iarobkova ND
Antibiotiki; 1968 Feb; 13(2):181-5. PubMed ID: 5667948
[No Abstract] [Full Text] [Related]
19. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
Hamilton-Miller JM
Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
[No Abstract] [Full Text] [Related]
20. Clinical isolates of Canada albicans.
Holt RJ
Infection; 1979; 7(3):154-5. PubMed ID: 383625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
